Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asarfi HospitalBOM:543943 +2.01%78 Return-on-Tangible-Equity is 16.38% as of Mar. 2026, which is 17% below its 10-year median of 19.66. GuruFocus rates BOM:543943 with a GF Score™ of 78/100 and a GF Value™ of ₹198.10 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Asarfi Hospital ranks better than 65.68% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Asarfi Hospital's annualized net income for the quarter that ended in Mar. 2026 was ₹157 Mil. Asarfi Hospital's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹957 Mil. Therefore, Asarfi Hospital's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 16.38%.
The historical rank and industry rank for Asarfi Hospital's Return-on-Tangible-Equity or its related term are showing as below:
BOM:543943'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.41 Med: 19.66 Max: 28.99
Current: 18.73
During the past 7 years, Asarfi Hospital's highest Return-on-Tangible-Equity was 28.99%. The lowest was 7.41%. And the median was 19.66%.
BOM:543943's Return-on-Tangible-Equity is ranked better than 65.68% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs BOM:543943: 18.73
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Asarfi Hospital Return-on-Tangible-Equity Related Terms
Asarfi Hospital Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Asarfi Hospital's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543943 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Asarfi Hospital's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asarfi Hospital Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Asarfi Hospital's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Asarfi Hospital's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 16.38% mean?
Asarfi Hospital (BOM:543943) has a Return-on-Tangible-Equity of 16.38% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asarfi Hospital and its competitors. This is 17% below median its historical median of 19.66. Over the past decade, Asarfi Hospital's Return-on-Tangible-Equity has ranged from 7.41 to 28.99. According to the industry distribution chart, Asarfi Hospital ranks #198 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 34.3%.
Is Asarfi Hospital's Return-on-Tangible-Equity too high?
Asarfi Hospital's current Return-on-Tangible-Equity of 16.38% is 17% below median its 10-year median of 19.66. Over the past 10 years, this metric has ranged from a low of 7.41 to a high of 28.99. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.62. Asarfi Hospital's value of 16.38% is 54.2% above this industry median. Based on the distribution chart, Asarfi Hospital ranks #198 out of 577 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Asarfi Hospital has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asarfi Hospital's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Asarfi Hospital ranks #198 out of 577 companies for Return-on-Tangible-Equity. This puts Asarfi Hospital in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.62. Asarfi Hospital's value of 16.38% is 54.2% above this benchmark. Historically, Asarfi Hospital's own Return-on-Tangible-Equity has ranged from 7.41 to 28.99 over the past decade. While the company's 10-year median is 19.66 vs. the industry median of 10.62, Asarfi Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.62, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asarfi Hospital's current Return-on-Tangible-Equity of 16.38% is 54.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Asarfi Hospital and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asarfi Hospital's current Return-on-Tangible-Equity is 16.38%, which is 17% below median its own 10-year median of 19.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asarfi Hospital stock overvalued right now?
Based on GuruFocus' analysis, Asarfi Hospital (BOM:543943) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹198.10, compared to a current price of ₹226.30 — trading 14.2% above its estimated fair value. The current Return-on-Tangible-Equity is 16.38%, which is 17% below median its 10-year median of 19.66 and 54.2% above the Healthcare Providers & Services industry median of 10.62. Asarfi Hospital's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Asarfi Hospital (BOM:543943), the current Return-on-Tangible-Equity is 16.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asarfi Hospital (BOM:543943) Overvalued in 2026?
Based on GuruFocus' analysis, Asarfi Hospital stock appears to be overvalued.
The current stock price of ₹226.30 is trading 14.2% above its estimated GF Value™ of ₹198.10.
GuruFocus considers Asarfi Hospital to be Modestly Overvalued.
Key valuation signals for BOM:543943:
Return-on-Tangible-Equity: 16.38% (17% below median its 10-year median of 19.66)
GF Value™: ₹198.10 vs. price of ₹226.30 (14.2% above fair value)
Industry Position: 54.2% above the Healthcare Providers & Services median (#198 of 577)
No single metric tells the full story. See the BOM:543943 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asarfi Hospital Ltd provides healthcare facilities to the people of Jharkhand. It is a multi-specialty hospital offering healthcare facilities. The company is committed to delivering valued healthcare services to patients that include prevention, treatment, and proper rehabilitation.
78GF Score
Get the complete analysis for BOM:543943
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543943 has been successfully added to your 
